Biomerica (BMRA) Return on Capital Employed (2011 - 2026)

Biomerica has disclosed Return on Capital Employed across 16 years of filings, most recently posting 137.43% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 137.43%, down 18174.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 137.43% (down 18174.0% YoY), and the FY2025 annual result was 87.67%, down 10059.0% from the prior year.
• Return on Capital Employed came in at 137.43% for Q1 2026 at Biomerica, down from 108.67% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 44.31% in Q1 2025 to a low of 137.43% in Q1 2026.
• The 5-year median for Return on Capital Employed is 59.11% (2023), against an average of 53.12%.
• Across the five-year window, Return on Capital Employed surged 11771 bps in 2025 and plunged 18174 bps in 2026, its largest moves.
• Biomerica's Return on Capital Employed stood at 64.25% in 2022, then advanced by 8 bps to 59.11% in 2023, then soared by 151 bps to 30.28% in 2024, then tumbled by 459 bps to 108.67% in 2025, then slipped by 26 bps to 137.43% in 2026.
• The last three Return on Capital Employed figures came in at 137.43% (Q1 2026), 108.67% (Q4 2025), and 103.79% (Q3 2025), per Business Quant data.